IL-17-producing T cells can augment autoantibody-induced arthritis

Proceedings of the National Academy of Sciences of the United States of America

Volumn 106, Issue 51, 2009, Pages 21789-21794

  Jacobs, Jonathan P ^a   Wu, Hsin Jung ^a   Benoist, Christophe ^a   Mathis, Diane ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Arthritis model; Inflammation; Th17 cell

Indexed keywords

AUTOANTIBODY; INTERLEUKIN 17; MAJOR HISTOCOMPATIBILITY ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTHRITIS; ARTICLE; B LYMPHOCYTE; BONE MARROW TRANSPLANTATION; CD4+ T LYMPHOCYTE; CELL DIFFERENTIATION; CELL FUNCTION; CELL POPULATION; CONTROLLED STUDY; INNATE IMMUNITY; KRN TRANSGENE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS; T LYMPHOCYTE; TRANSGENE;

ANIMALS; ARTHRITIS; AUTOANTIBODIES; BLOOD; CELL DIFFERENTIATION; INTERLEUKIN-17; MICE; MICE, TRANSGENIC; NEUTRALIZATION TESTS; T-LYMPHOCYTES;

MUS;

EID: 76049088641     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.0912152106     Document Type: Article

References (43)

1. Lundy SK, Sarkar S, Tesmer LA, Fox DA (2007) Cells of the synovium in rheumatoid arthritis. T lymphocytes. Arthritis Res Ther 9:202.
2. Skapenko A, Leipe J, Lipsky PE, Schulze-Koops H (2005) The role of the T cell in autoimmune inflammation. Arthritis Res Ther 7 Suppl 2:S4 -14.
3. Monach PA, Benoist C, Mathis D (2004) The role of antibodies in mouse models of rheumatoid arthritis, and relevance to human disease. Adv Immunol 82:217-248.
4. Kouskoff V, et al. (1996) Organ-specific disease provoked by systemic autoimmunity. Cell 87:811-822.
5. Sawa S, et al. (2006) Autoimmune arthritis associated with mutated interleukin (IL)-6 receptor gp130 is driven by STAT3/IL-7-dependent homeostatic proliferation of CD4+ T cells. J Exp Med 203:1459-1470.
6. Wong PK, et al. (2006) Interleukin-6 modulates production of T lymphocyte-derived cytokines in antigen-induced arthritis and drives inflammation-induced osteoclastogenesis. Arthritis Rheum 54:158-168.
7. Wu HJ, et al. (2007) Inflammatory arthritis can be reined in by CpG-induced DC NK cell cross talk. J Exp Med 204:1911-1922.
8. Benoist C, Mathis D (2000) A revival of the B cell paradigm for rheumatoid arthritis pathogenesis? Arthritis Res 2:90-94.
9. Nandakumar KS, Holmdahl R (2006) Antibody-induced arthritis: Disease mechanisms and genes involved at the effector phase of arthritis. Arthritis Res Ther 8:223.
10. Kagari T, Doi H, Shimozato T (2002) The importance of IL-1 beta and TNF-alpha, and the noninvolvement of IL- 6, in the development of monoclonal antibody-induced arthritis. J Immunol 169:1459-1466.
11. Korganow AS, et al. (1999) From systemic T cell self-reactivity to organ-specific autoimmune disease via immunoglobulins. Immunity 10:451-461.
12. Matsumoto I, Staub A, Benoist C, Mathis D (1999) Arthritis provoked by linked T and B cell recognition of a glycolytic enzyme. Science 286:1732-1735.
13. Kitamura D, Roes J,KuhnR, RajewskyK(1991)ABcell-deficientmousebytargeted disruption of the membrane exon of the immunoglobulin mu chain gene. Nature 350:423-426.
14. Kaye J, et al. (1989) Selective development ofCD4+T cells in transgenic mice expressing a class II MHC-restricted antigen receptor. Nature 341:746-749.
15. Yamashiro H, Hozumi N, Nakano N (2002) Development of CD25(+) T cells secreting transforming growth factor-beta1 by altered peptide ligands expressed as selfantigens. Int Immunol 14:857-865.
16. Faulkner L, et al. (2005) The mechanism of superantigen-mediated toxic shock: Not a simple Th1 cytokine storm. J Immunol 175:6870-6877.
17. Ohmura K, et al. (2005) Interleukin-4 can be a key positive regulator of inflammatory arthritis. Arthritis Rheum 52:1866-1875.
18. Park H, et al. (2005) A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat Immunol 6:1133-1141.
19. Weaver CT, Hatton RD, Mangan PR, Harrington LE (2007) IL-17 family cytokines and the expanding diversity of effector T cell lineages. Annu Rev Immunol 25:821-852.
20. Constantinescu CS, et al. (1998) Antibodies against IL-12 prevent superantigen-induced and spontaneous relapses of experimental autoimmune encephalomyelitis. J Immunol 161:5097-5104.
21. Riedemann NC, et al. (2003) Protective effects of IL-6 blockade in sepsis are linked to reduced C5a receptor expression. J Immunol 170:503-507.
22. Bettelli E, et al. (2006) Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441:235-238.
23. Sutton C, et al. (2006) A crucial role for interleukin (IL)-1 in the induction of IL-17-producing T cells that mediate autoimmune encephalomyelitis. J Exp Med 203:1685-1691.
24. Veldhoen M, et al. (2006) TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity 24:179-189.
25. Korn T, et al. (2007) IL-21 initiates an alternative pathway to induce proinflammatory T(H)17 cells. Nature 448:484-487.
26. Ivanov II, et al. (2008) Specific microbiota direct the differentiation of IL-17-producing T-helper cells in the mucosa of the small intestine. Cell Host Microbe 4:337-349.
27. Hirota K, et al. (2007) T cell self-reactivity forms a cytokine milieu for spontaneous development of IL-17+ Th cells that cause autoimmune arthritis. J Exp Med 204:41-47.
28. Ji H, et al. (2002) Critical roles for interleukin-1 and tumor necrosis factor-α in antibody-induced arthritis. J Exp Med 196:77-85.
29. Murphy CA, et al. (2003) Divergent pro- and antiinflammatory roles for IL-23 and IL-12 in joint autoimmune inflammation. J Exp Med 198:1951-1957.
30. Nakae S, Nambu A, Sudo K, Iwakura Y (2003) Suppression of immune induction of collagen-induced arthritis in IL-17-deficient mice. J Immunol 171:6173-6177.
31. Koenders MI, et al. (2005) Blocking of interleukin-17 during reactivation of experimental arthritis prevents joint inflammation and bone erosion by decreasing RANKL and interleukin-1. Am J Pathol 167:141-149.
32. Nakae S, et al. (2003) IL-17 production from activated T cells is required for the spontaneous development of destructive arthritis in mice deficient in IL-1 receptor antagonist. Proc Natl Acad Sci USA 100:5986-5990.
33. Lubberts E, et al. (2005) Requirement of IL-17 receptor signaling in radiation-resistant cells in the joint for full progression of destructive synovitis. J Immunol 175:3360-3368.
34. Kolls JK, Linden A (2004) Interleukin-17 family members and inflammation. Immunity 21:467-476.
35. Chabaud M, et al. (2001) IL-17 derived from juxta-articular bone and synovium contributes to joint degradation in rheumatoid arthritis. Arthritis Res 3:168-177.
36. Schwarzenberger P, et al. (2000) Requirement of endogenous stem cell factor and granulocyte-colony-stimulating factor for IL-17-mediated granulopoiesis. J Immunol 164:4783-4789.
37. Sato K, et al. (2006) Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction. J Exp Med 203:2673-2682.
38. Koenders MI, et al. (2006) Interleukin-17 acts independently of TNF-alpha under arthritic conditions. J Immunol 176:6262-6269.
39. Nguyen LT, Jacobs J, Mathis D, Benoist C (2007) Where FoxP3-dependent regulatory T cells impinge on the development of inflammatory arthritis. Arthritis Rheum 56:509-520.
40. Mucida D, et al. (2007) Reciprocal Th-17 and regulatory T cell differentiation mediated by retinoic acid. Science 317:256-260.
41. Hsu HC, et al. (2008) Interleukin 17-producing T helper cells and interleukin 17 orchestrate autoreactive germinal center development in autoimmune BXD2 mice. Nat Immunol 9:166-175.
42. Svensson L, Jirholt J, Holmdahl R, Jansson L (1998) B cell-deficient mice do not develop type II collagen-induced arthritis (CIA). Clin Exp Immunol 111:521-526.
43. O'Neill SK, et al. (2005) Antigen-specific B cells are required as APCs and autoantibody-producing cells for induction of severe autoimmune arthritis. J Immunol 174:3781-3788.